Geron Corporation (GERN)
NASDAQ·Healthcare·Biotechnology
$1.52
-0.65%
Mkt Cap $960.82M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $50.42M | $48.02M | -4.78% | -$0.03 | -$0.03 | +0.00% | — | — |
| Q4 2025 Nov 5, 2025 | $53.34M | $47.23M | -11.46% | -$0.04 | -$0.03 | +18.19% | — | — |
| Q3 2025 Aug 6, 2025 | $47.30M | $49.04M | +3.66% | -$0.03 | -$0.02 | +33.33% | — | — |
| Q2 2025 May 7, 2025 | $51.81M | $39.60M | -23.56% | -$0.04 | -$0.03 | +25.00% | — | — |
| Q1 2025 Feb 26, 2025 | $45.29M | $47.54M | +4.97% | -$0.04 | -$0.04 | +0.00% | — | — |
| Q4 2024 Nov 7, 2024 | $62.16M | $28.27M | -54.52% | -$0.09 | -$0.04 | +55.56% | — | — |
| Q3 2024 Aug 8, 2024 | $270.00K | $882.00K | +226.67% | -$0.11 | -$0.10 | +9.09% | — | — |
| Q2 2024 May 2, 2024 | $270.00K | $304.00K | +12.59% | -$0.10 | -$0.09 | +10.00% | — | — |
| Q1 2024 Feb 28, 2024 | $70.00K | $23.00K | -67.14% | -$0.10 | -$0.09 | +10.00% | — | — |
| Q4 2023 Nov 2, 2023 | $70.00K | $164.00K | +134.29% | -$0.10 | -$0.08 | +20.00% | — | — |
| Q3 2023 Aug 3, 2023 | $70.00K | $29.00K | -58.57% | -$0.08 | -$0.09 | -12.50% | — | — |
| Q2 2023 May 11, 2023 | $80.00K | $21.00K | -73.75% | -$0.09 | -$0.07 | +22.22% | — | — |
| Q1 2023 Mar 16, 2023 | $120.00K | $103.00K | -14.17% | -$0.11 | -$0.10 | +9.09% | — | — |
| Q4 2022 Nov 3, 2022 | $87.17K | $297.00K | +240.73% | -$0.09 | -$0.10 | -11.11% | — | — |
| Q3 2022 Aug 11, 2022 | $114.60K | $73.00K | -36.30% | -$0.09 | -$0.07 | +22.22% | — | — |
| Q2 2022 May 9, 2022 | $102.25K | $123.00K | +20.29% | -$0.11 | -$0.09 | +18.18% | — | — |
| Q1 2022 Mar 10, 2022 | $77.25K | $1.04M | +1246.28% | -$0.08 | -$0.10 | -25.00% | — | — |
| Q4 2021 Nov 9, 2021 | $60.00K | $109.00K | +81.67% | -$0.09 | -$0.08 | +11.11% | — | — |
| Q3 2021 Aug 16, 2021 | $60.00K | $107.00K | +78.33% | -$0.09 | -$0.09 | +0.00% | — | — |
| Q2 2021 May 10, 2021 | $119.88K | $137.00K | +14.29% | -$0.08 | -$0.09 | -12.50% | — | — |